Unformatted Attachment Preview
Actions of Prostaglandins
Prostaglandins act by binding to different G-protein coupled receptors that in
return activate or inhibit adenylyl cyclase or stimulate phospholipase C. That
eventually results in an enhanced formation of diacylglycerol and inositol 1,4,5trisphosphate. Prostaglandin F2α (PGF2α), the leukotrienes, and thromboxane A2
(TXA2) activate phosphatidylinositol metabolism to perform certain functions.
Thus, activation of phosphatidylinositol metabolism leads to an increase in
intracellular Ca2+.
Prostaglandins, produced inside tissues, serve as local signals and the response
depends on specific cell types. The functions of prostaglandins and other
eicosanoids are diverse and depend on the tissue and enzymes present at the site
of action.
For instance, TXA2 released from platelets due to tissue injury, cause an increase
in bringing up new platelets for aggregation to the site of injury and also
contributes to local vasoconstriction. Whereas PGI2 is produced by endothelial
cells and its role is opposite to TXA2, PGI2 inhibits platelet aggregation and
produces vasodilation.
Therapeutic use of Prostaglandins
Prostaglandins play an important role in the regulation of pain, inflammation, and
fever. They are also involved in the regulation of many physiological functions,
such as acid secretion and mucus formation in the gastrointestinal (GI) tract,
contractions of the uterus, and blood flow of the kidney. Prostaglandins also play
a role as chemical mediators that are released during allergic and inflammatory
processes.
Major drugs targeting Prostaglandins
DRUG
Misoprostol
PROPERTIES
A PGE1 analog and
used to protect the
mucosal lining of
the stomach by
decreasing the
occurrence of
gastric and
duodenal ulcers
during chronic
NSAID treatment. It
is also used off label in obstetric
settings for labor
induction.
MECHANISM OF
ACTION
Misoprostol
interacts with
prostaglandin
receptors on parietal
cells present in the
stomach and
reduces gastric acid
secretion. It shows a
gastric intestinal
cytoprotective effect
by stimulation of
mucus and
bicarbonate
production. It
enhances uterine
contractions by
interacting with
prostaglandin
receptors in the
uterus.
SIDE EFFECTS
It has a potential
risk of abortion,
thus,
contraindicated
during pregnancy.
Common side
effects are diarrhea
headache,
abdominal pain,
and spotting (in
women).
If used off -label
for labor induction,
for termination of
pregnancy, or for
cervical ripening,
misoprostol can
cause maternal or
fetal complications
such as death,
uterine damage,
infection, and fetal
bradycardia.
Iloprost
A synthetic analog
of PGI2(prostacyclin)
and is a potential
agent for pulmonary
vasodilation so it
can be used as a
therapeutic drug for
pulmonary arterial
hypertension.
Iloprost is given as
pulmonary
inhalation and
causes a localized
effect of a decrease
in pulmonary
hypertension. The
administration of
drugs through
pulmonary
inhalation is
beneficial as it
provides a more
localized effect with
less systemic blood
pressure reduction.
The repeated doses
are required due to
the short half-life of
the drug.
Iloprost causes a
notable reduction in
pulmonary arterial
resistance following
by increase in
cardiac index and
oxygen delivery.
Iloprost mediates its
function by
activating the IP
receptors
(prostacyclin
receptors), elevating
the formation of
intracellular cAMP
(cyclic adenosine
monophosphate).
Iloprost also inhibits
TXA2 production.
Due to iloprost
inhalation, cough
and bronchospasm
can be the adverse
effects. Common
side effects include
headache,
dizziness, flushing,
and fainting.
Latanoprost,
travoprost,
and
bimatoprost
Latanoprost is a
PGF2α analog that is
used as a
therapeutic drug for
elevated intraocular
latanoprost and
travoprost bind to
the prostaglandin FP
receptors and cause
an increase in
uveoscleral outflow
These drugs can
cause adverse
effects like blurred
vision, ocular
irritation, iris color
change (increased
pressure and openangle glaucoma.
Travoprost is a prodrug and become
active after
metabolized to free
acid. This drug is
given as ophthalmic
solution once per
day and as effective
as timolol(a
synthetic
compound) or even
better in decreasing
intraocular pressure.
(any nontrabecular
outflow in a normal
eye), decreasing
intraocular pressure.
Bimatoprost causes
similar effects as
latanoprost and
travoprost.
brown
pigmentation),
increased number
and pigment of
eyelashes, and
foreign body
sensation.
The administration
of alprostadil is
localized either by
Major side effects,
when used as
therapy for erectile
Bimatoprost mimics
endogenous
prostanoids
(prostaglandinethanolamides) and
has similar
effectiveness in
decreasing the
intraocular pressure.
Bimatoprost
enhances
prominence, length,
and darkness of
eyelash and also
used for treating
eyelash
hypotrichosis.
Alprostadil
It is a PGE1
produced naturally
in tissues, for
Lubiprostone
example, seminal
vesicles and
cavernous tissues, in
the ductus
arteriosus of the
fetus and in the
placenta.
Therapeutic
importance of
alprostadil is in the
treatment of erectile
dysfunction or in
keeping the ductus
arteriosus open in
those neonates that
have congenital
heart conditions
until surgery has
done. However,
usually, the ductus
closes soon after
delivery in order to
allow normal blood
circulation between
the heart and the
lungs.
suppository or by
injection. The drug
action occurs by
causing an increase
in intracellular cAMP
which subsequently
leads to the
activation of protein
kinase and
relaxation of smooth
muscle. Blood is
then entrapped by
dilation of
cavernosal arteries
and by the
relaxation of
trabecular smooth
muscles.
dysfunction, are
dizziness,
symptomatic
hypotension, and
syncope. Local
adverse reactions
include urethral,
penile, and
testicular pain;
prolonged
erections; and
priapism. When
administered
intravenously (IV)
in neonates, fever,
sepsis, apnea, and
seizures may be
the adverse
effects.
Lubiprostone is a
PGE1 derivative
used as a
therapeutic drug for
irritable bowel
syndrome with
constipation and
chronic idiopathic
constipation.
It exerts its effects
by stimulation of
chloride channels
(ClC-2) in the
luminal cells of the
intestinal epithelium,
thus cause an
increase in intestinal
fluid secretion. This
The common side
effect is nausea
that can be
decreased if drug
is taken with food.
The second most
reported adverse
effect is dosedependent
results in the
softening of the
stool and increases
intestinal motility
diarrhea that is
followed by
headache and
abdominal pain.
Name:
Description:
...